Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection.

ABSTRACT:

SUBMITTER: Sun F 

PROVIDER: S-EPMC9282758 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature